IL1B and colitis: To further understand the protective efficacy of PS, we analyzed the content of colitis-associated inflammatory cytokines and found that pretreatment with PS reduced the levels of pro-inflammatory cytokines, such as IL-1β, TNF-α, and IL-6, while increased anti-inflammatory TGF-β1 cytokine levels (Figure 4e).